Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Pricing of pharmaceuticals is becoming a major challenge for health systems

7 references·2 citing·43 second hop

FromToDepth

this work references cited by second hop

References

2016Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research889 cited
2011The cost of drug development: A systematic review510 cited
2015The $2.6 Billion Pill — Methodologic and Policy Considerations319 cited
2019Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval302 cited
2015The cost of multiple sclerosis drugs in the US and the pharmaceutical industry261 cited
2016Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis255 cited
2017A global comparison of the cost of patented cancer drugs in relation to global differences in wealth152 cited

Cited by

2021Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China116 cited
2020Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysis103 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work